PAS
BVS icon

Point72 Asia (Singapore)’s Bioventus BVS Stock Holding History

Point72 Asia (Singapore)’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-50,027
Closed -$260K – 1085
2024
Q1 		$260K Buy
50,027
+48,983
+4,692% +$239K 0.07% 329
2023
Q4 		$5.5K Buy
+1,044
New +$4.13K ﹤0.01% 528

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
JIC
Juniper Investment Company New York $313M AUM 79.58% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Point72 Asia (Singapore)'s BVS Position: Q2 2024 in Review

Point72 Asia (Singapore) sold out of Bioventus (BVS) in Q2 2024, closing a stake of 50,027 shares — an estimated $260K sold.

Point72 Asia (Singapore) first reported a position in BVS in Q4 2023 and held it in 2 quarters. The position peaked at $260K in Q1 2024. 102 funds tracked by Wall St. Rank hold BVS as of Q2 2024.

  • Point72 Asia (Singapore) reported no remaining Bioventus position as of Q2 2024 after selling out during the quarter.
  • Point72 Asia (Singapore) sold 50,027 Bioventus shares in Q2 2024, an estimated $260K.
  • Point72 Asia (Singapore) first reported a position in Bioventus in Q4 2023 and held it in 2 quarters.
  • Point72 Asia (Singapore)'s Bioventus position peaked at $260K in Q1 2024.
  • 102 funds tracked by Wall St. Rank held Bioventus as of Q2 2024.

Based on Point72 Asia (Singapore)'s 13F filing for Q2 2024, filed 14 Aug 2024.